Wishing a safe and happy #4thofJuly to everyone celebrating! 🎆
Scribe Therapeutics
Biotechnology Research
Alameda, CA 10,934 followers
CRISPR by Design™
About us
Scribe is enabling the creation of genetic medicines through its CRISPR by Design™ approach to genetic modification.
- Website
-
https://www.scribetx.com/
External link for Scribe Therapeutics
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Alameda, CA
- Type
- Privately Held
Locations
-
Primary
1150 Marina Village Pkwy
Alameda, CA 94501, US
Employees at Scribe Therapeutics
Updates
-
Next-generation #CRISPR technologies. In vivo therapies for sickle cell and cardiovascular disease. The future of genetic medicine, from gene editing to epigenetic editing. At #AspenIdeasHealth, our CEO Benjamin Oakes, Nobel Laureate and Innovative Genomics Institute founder Jennifer Doudna, and CRISPR Therapeutics CEO Samarth Kulkarni discussed these topics and more. Missed their Aspen Ideas discussion? Check out the video recording, now available on demand: https://lnkd.in/grDZ7wU7 The Aspen Institute #CRISPRbyDesign #GeneEditing #MolecularEngineering #EpigeneticEditing #GeneticMedicine
-
Livestream from #AspenIdeasHealth begins in 15 minutes! Watch the session on next-generation #CRISPR featuring our CEO Benjamin Oakes, Nobel Laureate and Innovative Genomics Institute founder Jennifer Doudna, and CRISPR Therapeutics CEO Samarth Kulkarni: https://ow.ly/l7iy50SmRNG Aspen Ideas The Aspen Institute #CRISPRbyDesign #GeneEditing #MolecularEngineering #EpigeneticEditing #GeneticMedicine
-
It’s the first day of #AspenIdeasHealth! Tomorrow, June 21, join our CEO Benjamin Oakes, scientific advisor and Innovative Genomics Institute founder Jennifer Doudna, and CRISPR Therapeutics CEO Samarth Kulkarni, for a fireside chat on how next-generation #CRISPR approaches can transform the lives of millions of patients globally. https://lnkd.in/e48pCUZ4 Aspen Ideas The Aspen Institute #CRISPRbyDesign #GeneEditing #MolecularEngineering #EpigeneticEditing #GeneticMedicine
-
On #WorldSickleCellDay, we recognize the important progress being made globally to address sickle cell disease. At Scribe, we're working with leading drug developers like Sanofi to bring in vivo #CRISPR-based therapies to patients in need. Learn more on our website: https://lnkd.in/eJ-WATsj #SickleCell #CRISPRbyDesign #GeneEditing #MolecularEngineering #EpigeneticEditing #GeneticMedicine
-
Attending #AspenIdeasHealth 2024 this week? Don't miss an important discussion on #CRISPR 2.0 featuring Jennifer Doudna (Nobel Laureate, Innovative Genomics Institute founder, Scribe co-founder and scientific advisor), Benjamin Oakes (Scribe co-founder and CEO), and Samarth Kulkarni (CRISPR Therapeutics CEO). Drs. Doudna, Oakes, and Kulkarni will discuss advances in next-generation genome editing technologies, strategies for broadening patient access to critical genetic medicines, and more. Details below and on the Aspen Ideas website: https://lnkd.in/g4Ch_dHR 📣 CRISPR 2.0, the Next Generation 📅 Friday, June 21, 2024 🕚 11:40 AM - 12:30 PM MDT 📍 Aspen, Colorado The Aspen Institute #CRISPR #CRISPRbyDesign #GeneEditing #MolecularEngineering #EpigeneticEditing #GeneticMedicine
-
Catch up on the scientific innovation and learnings shared at #BIO2024 with some great takeaways on scaling genetic medicine from our Chief Business Officer Svetlana Lucas: ➡️ Engineering for exquisite therapeutic activity, specificity, and delivery is paramount for one-and-done genetic medicines ➡️ Think early and intentionally about how to improve patient burden and access ➡️ Moving from ex vivo to in vivo treatments and utilizing non-viral delivery technologies will be key to bringing down the costs of life-changing treatments If you missed the session at BIO, watch it on demand today at https://ow.ly/LtxV50Sj17b. Thanks to Andrew Dunn and the rest of the Endpoints News team for hosting an insightful event. Biotechnology Innovation Organization #CRISPRbyDesign #GeneEditing #EpigeneticEditing #MolecularEngineering #GeneticMedicine
-
Our team is on the ground at the BIO International Convention this week! Interested in a meeting at #BIO2024 to learn about our CRISPR by Design™ approach and platforms for #CRISPR gene editing and epigenetic editing? Reach out through our website ➡️ https://lnkd.in/gGEjCrpa Biotechnology Innovation Organization #CRISPRbyDesign #GeneEditing #EpigeneticEditing #MolecularEngineering #GeneticMedicine
-
Our team is on the ground at the BIO International Convention this week! Interested in a meeting at #BIO2024 to learn about our CRISPR by Design™ approach and platforms for #CRISPR gene editing and epigenetic editing? Reach out through our website ➡️ https://lnkd.in/gGEjCrpa Biotechnology Innovation Organization #CRISPRbyDesign #GeneEditing #EpigeneticEditing #MolecularEngineering #GeneticMedicine
-
What’s next for genetic medicine? Find out at today's Endpoints News at #BIO2024 event, where our Chief Business Officer Svetlana Lucas will share her insights on how to bring treatments to as many people as possible, including through #CRISPR gene editing and epigenetic editing. The panel starts in one hour! https://lnkd.in/g7dF2StM #CRISPRbyDesign #GeneEditing #MolecularEngineering #EpigeneticEditing #GeneticMedicine